PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | C0011847|diabetes |
| Sentences | 35 |
| PubMedID- 20558353 | The early recurrence, viremia and more severe fibrosis after antiviral therapy have an impact on the occurrence of new-onset diabetes in hepatitis c positive patients. |
| PubMedID- PMC4034027 | Ifnα has been reported to induce symptoms of insulin-dependent type i diabetes in patients with chronic hepatitis c infection; for the most part in individuals with pre-existing autoimmunity and/or with a genetic predisposition [45,92]. |
| PubMedID- 19809411 | Objectives: chronic hepatitis b patients with diabetes and metabolic syndrome are at increased risk of cirrhosis and hepatocellular carcinoma, but the underlying mechanism is unclear. |
| PubMedID- 25379307 | Based on all these findings, diagnosis of autoimmune hepatitis with type 2 diabetes mellitus, coagulopathy, and ischemic heart disease was made. |
| PubMedID- 20536504 | Fulminant type 1 diabetes mellitus associated with acute hepatitis a. |
| PubMedID- 24353540 | Most cross-sectional studies comparing the prevalence of diabetes in patients with chronic hepatitis c with that of a comparator group have shown that patients infected with hcv present with diabetes more often than patients with chronic liver diseases of other etiologies, even at a pre-cirrhotic stage.15 this observation was confirmed by a vast general population-based survey and by several longitudinal studies.16 most of the risk affects patients with other cofactors of diabetes, suggesting that hcv infection may significantly increase the rate of developing glucose metabolism alterations in predisposed individuals. |
| PubMedID- 26332473 | Educational intervention in primary care residents' knowledge and performance of hepatitis b vaccination in patients with diabetes mellitus. |
| PubMedID- 23984431 | Multiple mechanisms have been accounted for insulin resistance and development of diabetes in patients with chronic hepatitis c. it promotes ir mainly through interfering with insulin signaling pathway in hepatocytes, increasing inflammatory response with production of cytokines such as tnf alpha and il-6 and increasing oxidative stress [16, 17]. |
| PubMedID- 22310786 | Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis c virus infection after renal transplantation. |
| PubMedID- 26390278 | diabetes and prediabetes in patients with hepatitis b residing in north america. |
| PubMedID- 26337813 | The impact of pnpla3 and jazf1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. |
| PubMedID- 22446023 | Subgroup analyses revealed that the positive associations were independent of geographic locations, alcohol consumption, history of diabetes or infections with hepatitis b (hbv) and/or hepatitis c virus (hcv). |
| PubMedID- 22933435 | The diabetes status of people with acute hepatitis infection is not routinely collected for national hepatitis surveillance purposes. |
| PubMedID- 20688613 | Sitagliptin in treatment of diabetes complicated by chronic hepatitis c. |
| PubMedID- 21645344 | Several additional studies have also assessed the prevalence of type 2 diabetes mellitus in patients with chronic hepatitis c infection, affecting between 8 and 25% of these patients [21,22]. |
| PubMedID- 21799928 | They included sex, age, baseline laboratory data: cd4 cell count, hiv viral load, and serum creatinine, and other medical conditions (antiretroviral treatment-naïve or experienced, concurrent ritonavir-boosted protease inhibitors, concurrent nephrotoxic drugs such as ganciclovir, sulfamethoxazole/trimethoprim, ciprofloxacin, and nsaids, diabetes mellitus, co-infection with hepatitis b defined by positive hepatitis b surface antigen, co-infection with hepatitis c defined by positive hcv viral load, hypertension defined by current treatment with antihypertensive agents, dyslipidemia defined by current treatment with lipid-lowering agents, and current smoking) [26]. |
| PubMedID- 25483516 | Normal or defective immune response to hepatitis b vaccine in patients with diabetes and celiac disease. |
| PubMedID- 20040053 | Aim: the aim of this study was to investigate an association between antidiabetic therapies and the incidence of hcc in hepatitis c patients with diabetes mellitus. |
| PubMedID- 22505448 | Chronic hepatitis b with type i diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy. |
| PubMedID- 23909647 | Pre-existing hypertension, obesity, and diabetes increased the risk of dyslipidemia, whereas hepatitis c virus, lower cd4(+) t cell count, and higher hiv viral load had a protective effect. |
| PubMedID- 22089377 | Occurrence of diabetes was not associated with hiv-related markers, hepatitis c, hypertension or family history of diabetes. |
| PubMedID- 22014765 | Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis c. |
| PubMedID- 22497813 | During the first nhanes cycle (1988-1994), insulin and diabetes were independently associated with hepatitis c. |
| PubMedID- 22218030 | Moreover, this risk escalates if diabetes coincides with chronic hepatitis c and cirrhosis. |
| PubMedID- 22236146 | Aim: the aim of this study was to evaluate the prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhotic patients with fasting plasma glucose (fpg) level of <126 mg/dl. |
| PubMedID- 25846548 | The cohorts of chronic hepatitis b with new onset diabetes (n = 2099) and 1:1 ratio age-, gender- and inception point (onset date of diabetes)- matched nondiabetes (n = 2080) were followed up from the inception point until development of hcc, withdrawal from insurance or december 2009. |
| PubMedID- 24523328 | When planning therapeutic interventions in chronic hepatitis c in patients with diabetes, it is considered the presence of visceral obesit , dyslipidemia, and hepatic steatosis. |
| PubMedID- 26441826 | There is also epidemiological evidence for increased prevalence of hepatitis c in patients with diabetes, and some authors find it reasonable to screen patients with diabetes and persistently elevated alt for hcv (196). |
| PubMedID- 23493666 | The clinical characteristics were collected in table 1, including gender, age, alcohol drinking, tobacco smoking, hypertension, diabetes mellitus, family history of hcc, hepatitis b virus ( hbv) serological markers, and serum alpha-fetoprotein (a-fp) levels. |
| PubMedID- 20666689 | Nafld/nash and type 2 diabetes mellitus, along with hepatitis c virus infection, were the major etiologic risk factors associated with hcc. |
| PubMedID- 22014257 | Multiple co-morbidities including diabetes (23% of patients), hypertension (36%), hepatitis c (43%), and depression (74%) were concurrently managed. |
| PubMedID- 21110426 | 4) the distribution of hcv genotypes in chronic hepatitis c patients with and without diabetes mellitus is not significantly different. |
| PubMedID- 22418268 | Insulin resistance and diabetes mellitus in patients with chronic hepatitis c: spectators or actors. |
| PubMedID- 22701277 | diabetes in patients with chronic hepatitis c infection (chc) has unique and complex pathogenesis, which distinguishes this metabolic disorder from type 2 diabetes mellitus. |
| PubMedID- 24932351 | Prevalence of hepatitis b virus in patients with diabetes mellitus: a comparative cross sectional study at woldiya general hospital, ethiopia. |
Page: 1